Flomics is a biotechnology company operating in the field of genomics, bioinformatics and NGS. We are developing a novel multicancer screening solution to be implemented in the clinical practice. Flomics also provides a complete range of personalized genomic services, with a fully compliant molecular biology laboratory and specialized bioinformatics department. Flomics was founded in 2018 by researchers of the Center of Genomic Regulation (CRG) and the Pompeu Fabra University (UPF), and is currently located in the beautiful Barcelona Biomedical Research Park (PRBB) building.
Our Mission
To improve clinical practice development of a multi-disease detection test from a standard blood sample.
Through a combination of AI and machine learning algorithms, we identify RNA changes associated with disease states in a faster, cheaper and non-invasive way.
Meet our Team
João Curado, PhD
CEO & Co-founder
Esther Lizano, PhD
CSO and Co-founder
Luís Korrodi, PhD
CBO & Co-founder
André Guedes, PhD
COO and Co-founder
Jennifer Perez, PhD
Scientific Lead
Julien Lagarde, PhD
Bioinformatics Lead
Lluc Cabús, MSc
PhD Student
Cristina Tuñí, MSc
Bioinformatician
Sonia Belmonte, MSc
Lab Technician
Alexandra Afonso, MSc
Business Developer
Samuel Santamaria, BSc
Bioinformatics Intern
Our advisory team
Roderic Guigó, PhD
Prof. & GL at CRG
Scientific Advisor
Rory Johnson, PhD
Prof. at UC Dublin
Scientific Advisor
Tomas Marques, PhD
Prof. & GL at UPF
Scientific Advisor
Albert Abad, MD
MD at Hospital Dexeus
Medical Advisor
Chris Beck, MSc
Head of TOMRA SEE
Business Advisor
André Lopes,MSc
Zurich Insurance
Software Advisor
